Privacy policy Consumer health data privacy Terms of use

Cookie policy Your privacy choices

© 2026 Sharecare, Inc.

Virtual journey: ATTR amyloidosis

Virtual journey: ATTR amyloidosis

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

Written by Jameson Kowalczyk.

Medically reviewed by nan.

Updated onNovember, 2026

Written by Jameson Kowalczyk.

Medically reviewed by nan.

Updated onNovember, 2026

Featured content

5 answers about ATTR amyloidosis

5 answers about ATTR amyloidosis

How ATTR amyloidosis affects different organs, and what people with this condition need to know about treatment.

What are the different types of amyloidosis?

What are the different types of amyloidosis?

A guide to three different types of amyloidosis, with a look at causes and underlying conditions.

How does ATTR cardiomyopathy impact your quality of life?

How does ATTR cardiomyopathy impact your quality of life?

Understanding quality of life and why it’s an important consideration when living with and treating ATTR-CM.

How to seek support when living with ATTR cardiomyopathy

How to seek support when living with ATTR cardiomyopathy

How ATTR cardiomyopathy may affect mental health and four strategies for seeking support.

ATTR-CM: helping a loved one manage multiple medications

ATTR-CM: helping a loved one manage multiple medications

Strategies for caregivers of people with ATTR-CM when a treatment plan involves taking multiple medications.